What is Vanda Pharmaceuticals Inc.'s Market Cap?

Vanda Pharmaceuticals Inc.'s Market Cap is $328.9M, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s Enterprise Value?

Vanda Pharmaceuticals Inc.'s Enterprise Value is $280.2M, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s Price / Sales?

Vanda Pharmaceuticals Inc.'s Price / Sales is 1.5×, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s EV / Revenue?

Vanda Pharmaceuticals Inc.'s EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s EV / EBITDA?

Vanda Pharmaceuticals Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s Revenue (TTM)?

Vanda Pharmaceuticals Inc.'s Revenue (TTM) is $215.7M, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s Net Income (TTM)?

Vanda Pharmaceuticals Inc.'s Net Income (TTM) is -$274.9M, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s EBITDA?

Vanda Pharmaceuticals Inc.'s EBITDA is -$177.0M, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s Diluted EPS (TTM)?

Vanda Pharmaceuticals Inc.'s Diluted EPS (TTM) is -4.55, based on as-reported figures from SEC (XBRL) filings.

What is Vanda Pharmaceuticals Inc.'s EBITDA Margin?

Vanda Pharmaceuticals Inc.'s EBITDA Margin is -82.1%, based on as-reported figures from SEC (XBRL) filings.

Vanda Pharmaceuticals Inc. (VNDA) Financial Statements

Vanda Pharmaceuticals Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SP95N5

XNAS · usd

5.44▲ 0.11 (2.06%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close5.33

Day's Range5.23 – 5.45

52-Week Range4.27 – 10.30

Volume613.0K

Avg Volume901.4K

Share Statistics

Shares Outstanding

Employees533

ExchangeXNAS

Listed2006-04-12

Share count as of July 30, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Vanda Pharmaceuticals Inc. (VNDA)

What is Vanda Pharmaceuticals Inc.'s Market Cap?: Vanda Pharmaceuticals Inc.'s Market Cap is $328.9M, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s Enterprise Value?: Vanda Pharmaceuticals Inc.'s Enterprise Value is $280.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s Price / Sales?: Vanda Pharmaceuticals Inc.'s Price / Sales is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s EV / Revenue?: Vanda Pharmaceuticals Inc.'s EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s EV / EBITDA?: Vanda Pharmaceuticals Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s Revenue (TTM)?: Vanda Pharmaceuticals Inc.'s Revenue (TTM) is $215.7M, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s Net Income (TTM)?: Vanda Pharmaceuticals Inc.'s Net Income (TTM) is -$274.9M, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s EBITDA?: Vanda Pharmaceuticals Inc.'s EBITDA is -$177.0M, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s Diluted EPS (TTM)?: Vanda Pharmaceuticals Inc.'s Diluted EPS (TTM) is -4.55, based on as-reported figures from SEC (XBRL) filings.
What is Vanda Pharmaceuticals Inc.'s EBITDA Margin?: Vanda Pharmaceuticals Inc.'s EBITDA Margin is -82.1%, based on as-reported figures from SEC (XBRL) filings.